Clinical Trials Sponsored by Brust-Zentrum AG

Total 81 results

Brust-Zentrum AG

Completed

SKINI - Radicality of Skin-Sparing and Nipple-Sparing Mastectomy (SKINI)

Surgery

Switzerland
Brust-Zentrum AG

Not yet recruiting

Patient Reported Outcomes After Oncoplastic Breast Conserving Surgery

Breast Cancer Stage I | Breast Cancer Stage II | Breast Cancer in Situ
Brust-Zentrum AG

Completed

Ex-vivo Performance Evaluation of the Histolog™ Scanner for Human Breast Carcinoma Detection on Fresh Breast Core Biopsies

Breast Cancer

Switzerland
Constanze Elfgen

Recruiting

Marker Technique Comparison in Targeted Axillary Dissection (MALLORCA)

Breast Cancer

Switzerland
Thomas Riegler
University of Zurich

Completed

Impact of Chair Seat Height on the 1-Minute Sit to Stand Test Performance in Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease | COPD

Switzerland
University Hospital, Brest
Sensimed AG

Unknown

Measurement of Ocular Tensional Fluctuation by Triggerfish Lens Before and After Cataract Surgery in Patients With Exfoliative Glaucoma (TRIGGERFISH)

Cataract | Exfoliative Glaucoma

France
Bio-Strath AG
Zentrum für Adipositas- und Stoffwechselmedizin Winterthur GmbH

Unknown

Influence of a Food Supplement on the Gut Microbiome in Healthy Obese Women

Overweight

Switzerland
Gaia AG
University Hospital, Saarland; Zentrum für Integrative Psychiatrie Kiel

Recruiting

Researching the Effectiveness of Attexis, a Digital Health Application for Adults With Attention Deficit Hyperactivity Disorder (READ-ADHD)

Adult Attention Deficit Hyperactivity Disorder

Germany
Thimo Marcin
Bern University of Applied Sciences

Completed

Nutritional Therapy in Patients at Risk for Malnutrition and Sarcopenia in Pulmonary Rehabilitation

Malnutrition | Sarcopenia

Switzerland
Academisch Medisch Centrum - Universiteit van Amsterdam...
Pregnolia AG

Recruiting

Cervical Softening and the Prediction of Preterm Birth (STIPP)

Premature Birth | Preterm Birth | Diagnosis | Threatened Preterm Labor | Cervical Incompetence in Pregnancy as Antepartum Condition | Premature Labor | Cervical Incompetence, With Delivery

Netherlands
A. Vogel AG
Cantonal Hospital of St. Gallen; Labormedizinisches Zentrum Dr. Risch

Completed

Superiority of Newly Developed Over Basic Echinacea Formulations for the Treatment of Respiratory Tract Infections

Respiratory Tract Infections

Switzerland
Lindenhofgruppe AG
Lindenhofstiftung; Labormedizinisches Zentrum Dr. Risch; Clinical Trials Unit...

Completed

Preoperative Decolonization and Surgical Site Infections - a Prospective Randomized Trial (DECO-SSI)

Surgical Site Infection | Orthopedic Disorders

Switzerland
Manchester University NHS Foundation Trust
Fresenius AG

Completed

Peptide GAM Immunoadsorption Therapy in Autoimmune Membranous Nephropathy (PRISM)

Autoimmune Membranous Nephropathy

United Kingdom
Berner Reha Zentrum AG
University of Zurich; Zurich University of Applied Sciences; Insel Gruppe AG,...

Recruiting

Self-efficacy and Well-being of Patients With Fibrotic Interstitial Lung Disease

Quality of Life | Interstitial Lung Disease | Self Efficacy | Self-management | Patient Education | Fibrotic Lung Disease

Switzerland
Academisch Medisch Centrum - Universiteit van Amsterdam...
Roche Pharma AG

Completed

Feasibility Study of Chemoradiation, TRAstuzumab and Pertuzumab in Resectable HER2+ Esophageal Carcinoma (TRAP)

Esophageal Carcinoma

Netherlands
Academisch Medisch Centrum - Universiteit van Amsterdam...
Hamilton Medical AG

Terminated

Does Automated Closed-Loop Ventilation Reduce the DRiving Pressure Levels in Patients With ARDS (AiRDRoP)

ARDS

Netherlands
Royal Marsden NHS Foundation Trust
Roche Pharma AG

Completed

Capecitabine and Oxaliplatin Plus Bevacizumab as Neoadjuvant Treatment for Untreated Unresectable Liver-only Metastases From Colorectal Cancer

Metastatic Colorectal Cancer

United Kingdom
Royal Free Hampstead NHS Trust
Roche Pharma AG

Completed

Lopinavir Capsules to Kaletra or Invirase Tablets (LoCKIT)

HIV Infections

United Kingdom
Pennine Acute Hospitals NHS Trust
Roche Pharma AG

Unknown

Reinfection and Long Term Outcomes in Intravenous Drug Users (IVDUs) After Hepatitis C Treatment

Hepatitis C

United Kingdom
London North West Healthcare NHS Trust
Fresenius AG

Unknown

A Trial of Taurine Supplementation in Parenteral Nutrition 1

Cholestasis

United Kingdom
Michael Rufer
University of Zurich

Enrolling by invitation

Integrated Care After Repeated Psychiatric Hospital Stays - Evaluation of an Interdisciplinary Treatment Program (INTUK)

Health Care Utilization | Chronic Psychiatric Disorder | Psychiatric Hospitalization | Intensive Care Psychiatric Disorder | Rehospitalization | High Utilization / Heavy Use

Switzerland
LimmaTech Biologics AG
Wellcome Trust; Naval Medical Research Center

Completed

Safety and Tolerability of a Bioconjugate Vaccine Against Shigella Flexneri 2a

Shigellosis

United States
Cambridge University Hospitals NHS Foundation Trust
Roche Pharma AG

Completed

Pilot Study of Rituximab Therapy for Systemic Lupus Erythematosus (SLE) and Vasculitis

Systemic Lupus Erythematosus | ANCA Associated Vasculitis

United Kingdom
Cambridge University Hospitals NHS Foundation Trust
Advanced Bionics AG

Completed

Bimodal, CROS and Severe Profound Hearing Loss Study

Hearing Loss, Bilateral | Cochlear Implant | Hearing Loss, Cochlear | Severe-Profound Hearing Loss

United Kingdom
Western Health and Social Care Trust
Roche Pharma AG

Unknown

CINtec PLUS Triage in HPV Primary Screening

Cervical Cancer

United Kingdom
Friedemann Paul
Beuth Hochschule für Technik Berlin; NovaVision AG, Zentrum für Sehtherapie

Completed

Visual Reconstitution Therapy After Optic Neuritis (VISION)

Multiple Sclerosis | Optic Neuritis

Germany
Nottingham University Hospitals NHS Trust
University of Nottingham; Sonova AG

Completed

Evaluation of the eAdjust Application

Hearing Loss, Sensorineural | Hearing Loss, Bilateral

United Kingdom
Birmingham Women's and Children's NHS Foundation...
Roche Pharma AG

Terminated

A Pilot Trial of Pediatric Liver Transplantation Without Steroids

Evidence of Liver Transplantation

United Kingdom
Royal Marsden NHS Foundation Trust
Merck KGaA, Darmstadt, Germany; 4SC AG

Unknown

Epigenetic Modulation of the immunE Response in GastrointEstinal Cancers (EMERGE) (EMERGE)

Cancer | GI Cancer

United Kingdom
University Hospital Southampton NHS Foundation...
Roche Pharma AG; Cancer Research UK

Recruiting

Atezolizumab Immunotherapy, in Immunotherapy Naive Patients With Urinary Tract Squamous Cell Carcinoma (UTSCC). (AURORA)

Squamous Cell Carcinoma | Urinary Tract Cancer

United Kingdom
The Christie NHS Foundation Trust
Manchester University NHS Foundation Trust; Aptus Clinical Ltd.; Zenzium Ltd.

Completed

COntinuous Signs Monitoring In Covid-19 Patients (COSMIC-19)

COVID-19

United Kingdom
Queen Mary University of London
Roche Pharma AG; Barts & The London NHS Trust

Completed

Under and Over Rehabilitation Study

Multiple Sclerosis

United Kingdom
Christian Buske
Roche Pharma AG; University of Ulm; Zentrum für Klinische Studien Ulm; X-act Cologne... and other collaborators

Active, not recruiting

Obinutuzumab in Marginal Zone Lymphoma

Marginal Zone Lymphoma

Germany
Oviva AG
Bern University of Applied Sciences; Swiss Commission for Technology and Innovation and other collaborators

Completed

Weight-loss Treatment Through Smartphone-assisted Dietary Coaching (Oviva)

Obesity | Overweight

Switzerland
LimmaTech Biologics AG
KEMRI-Wellcome Trust Collaborative Research Program; Kenya Medical Research...

Completed

A Study to Determine If a New Shigella Vaccine is Safe, Induces Immunity and The Best Dose Among Kenyan Infants

Shigellosis

Kenya
Lisa Bax
Roche Pharma AG; Genentech, Inc.

Terminated

Hedgehog Inhibition for Pancreatic Ductal Adenocarcinoma (PDAC) in the Preoperative Setting (HIPPoS) (HIPPoS)

Pancreatic Ductal Adenocarcinoma

United Kingdom
University Hospitals Coventry and Warwickshire...
Immunic AG; University of Warwick; MODEPHARMA

Completed

IMU-838 and Oseltamivir in the Treatment of COVID-19 (IONIC)

Covid 19

United Kingdom
Peripal AG
University Hospital Birmingham NHS Foundation Trust; Swiss Federal Institute...

Completed

Human Factors Validation Testing for the Peripal System; a Manual Connection Assist Device for Peritoneal Dialysis Devices

Renal Failure | Peritoneal Dialysis | Renal Replacement Therapy | End Stage Renal Failure on Dialysis | End Stage Renal Disease on Dialysis

United Kingdom
Odense University Hospital
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); European... and other collaborators

Completed

S.C. Immunotherapy With BM41 in Patients With Allergic Rhino-conjunctivitis Caused by Birch Pollen (BM41)

Allergic Rhinoconjunctivitis | Birch Pollen Allergy

Denmark
Royal Marsden NHS Foundation Trust
Pfizer; Roche Pharma AG; Institute of Cancer Research, United Kingdom

Unknown

PIPA: Combination of PI3 Kinase Inhibitors and PAlbociclib (PIPA)

Breast Cancer | Advanced Solid Tumours

United Kingdom
University Hospital, Brest
Novartis; Roche Pharma AG; Ministry of Health, France; Genzyme, a Sanofi Company

Completed

mTor-inhibitor (EVERolimus) Based Immunosuppressive Strategies for CNI Minimisation in OLD for Old Renal Transplantation (EVEROLD)

Renal Transplant

France
University of Liverpool
Roche Pharma AG; Cancer Research UK; Liverpool University Hospitals NHS Foundation...

Unknown

A Trial Looking at Rituximab and Chemotherapy as a Treatment for Follicular Lymphoma in Elderly Patients (PACIFICO)

Follicular Lymphoma

United Kingdom
Papworth Hospital NHS Foundation Trust
Roche Pharma AG; National Institute for Health Research, United Kingdom

Completed

A Therapeutic Open Label Study of Tocilizumab in the Treatment of Pulmonary Arterial Hypertension (TRANSFORM-UK)

Pulmonary Arterial Hypertension

United Kingdom
Manchester University NHS Foundation Trust
Roche Pharma AG; Imperial College London; University of Manchester; Unity Insights

Recruiting

Real-world Elecsys® GAAD Implementation and Validation to Improve Surveillance and Early Detection of HCC (REVISE-HCC)

Liver Cirrhosis | Hepatocellular Carcinoma

United Kingdom
University Hospital, Brest
University Hospital, Antwerp; Leiden University Medical Center; Insel Gruppe...

Recruiting

Safety and Efficiency of the YEARS Algorithm Versus Computed Tomography Pulmonary Angiography Alone for Suspected Pulmonary Embolism in Patients With Malignancy (HYDRA)

Cardiovascular Diseases | Vascular Diseases | Respiratory Tract Diseases | Lung Diseases | Cancer | Embolism | Embolism and Thrombosis | Pulmonary Embolism | Diagnosis

Netherlands, Spain, France, Switzerland, Italy, Belgium
Manchester University NHS Foundation Trust
University of Manchester; The Christie NHS Foundation Trust; Zenzium AI Ltd.; Aptus... and other collaborators

Recruiting

Enhanced Monitoring for Better Recovery and Cancer Experience in Greater Manchester (EMBRaCE-GM)

Colorectal Cancer | Lung Cancer | Hematological Cancer | CAR T-Cell Therapy

United Kingdom
Cambridge University Hospitals NHS Foundation Trust
University of Pennsylvania; Roche Pharma AG; Genentech, Inc.; Arthritis Research...

Completed

Rituximab Vasculitis Maintenance Study (RITAZAREM)

Microscopic Polyangiitis | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | Wegener Granulomatosis

United States, Canada, United Kingdom, Sweden, New Zealand, Ireland, Australia, Italy, Czechia, Japan
Undine Lehmann, Dr.
Rehab Basel; Berner Reha Zentrum AG; Klinik Barmelweid; University Department of... and other collaborators

Completed

The Prevalence of Malnutrition and Sarcopenia in Swiss Rehabilitation Settings (Malnut-Reha)

Malnutrition | Sarcopenia

Switzerland
Marc Righini
University Hospital, Angers; University Hospital, Brest; Academisch Medisch Centrum...

Completed

Age-adjusted D-dimer Cut-off Levels to Rule Out Pulmonary Embolism (ADJUST)

Pulmonary Embolism

Switzerland, France, Netherlands
Institut für Klinische Krebsforschung IKF GmbH...
Charite University, Berlin, Germany; Roche Pharma AG; Hoffmann-La Roche; Arbeitsgemeinschaft... and other collaborators

Recruiting

Rituximab in Combination With Glofitamab and Polatuzumab Vedotin in Patients With Previously Untreated Aggressive B-cell Lymphoma Ineligible for R-CHOP (R-Pola-Glo)

Lymphoma, Large B-Cell, Diffuse

Germany, Austria

Clinical Trials Sponsored by Brust-Zentrum AG

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Albania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations